(Q37643415)

21 August 2017

1 reference

title

Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms (English)

1 reference

21 August 2017

1 reference

Douglas A Drossman

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 December 2009

1 reference

The American Journal of Gastroenterology

21 August 2017

published in

1 reference

21 August 2017

volume

104

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

2897-2902

1 reference

Severe and refractory chronic abdominal pain: treatment strategies

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Psychotropic agents in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

An evidence-based position statement on the management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Not all side effects associated with tricyclic antidepressant therapy are true side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Prokinetics and fundic relaxants in upper functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Cognitive role of neurogenesis in depression and antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Does stress damage the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Patients with pain disorder show gray-matter loss in pain-processing structures: a voxel-based morphometric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Serotonin and neuroprotection in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

The narcotic bowel syndrome: clinical features, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Combination of antidepressants and psychological treatments for bulimia nervosa: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

The effect of gabapentin on neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.341

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.341

1 reference

Dimensions Publication ID

21 August 2017

1000499629

0 references

Fatcat ID

release_v4veccfbh5hxhf3e5x7vqerzj4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v4veccfbh5hxhf3e5x7vqerzj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference